文献速递骨软组织肉瘤与黑色素瘤

不同软组织肿瘤亚型对隔离肢体灌注治疗的反应率差异:一项国际多中心研究

Variation in response rates to isolated limb perfusion in different soft-tissue tumour subtypes: an international multi-centre study.
PubMed 文献 · Eur J Cancer · 2023-06-20

该国际多中心回顾性队列纳入17个专业隔离肢体灌注中心的1109例肢体软组织肉瘤患者,比较不同组织学亚型对美法仑为基础隔离肢体灌注的反应率。93%使用重组人肿瘤坏死因子α,总体反应率和完全缓解率显著优于单用美法仑,各组织学亚组间无显著差异;卡波西肉瘤、血管肉瘤和透明细胞肉瘤反应率较高。

要点

  • 1109例肢体软组织肉瘤患者接受美法仑为基础隔离肢体灌注,93%联合重组人肿瘤坏死因子α。
  • 联合重组人肿瘤坏死因子α组总体反应率68%(完全缓解17%),显著优于单用美法仑组。
  • 卡波西肉瘤完全缓解42%、总体反应率96%,血管肉瘤完全缓解45%,透明细胞肉瘤完全缓解31%。

核心结论

  • 隔离肢体灌注在所有肢体软组织肉瘤亚型中均获得较高的反应率和保肢率,但不同亚型间存在显著差异,卡波西肉瘤、血管肉瘤和透明细胞肉瘤结果最具前景。

研究设计与样本

  • 国际多中心回顾性队列研究,纳入17个专业隔离肢体灌注中心的1109例肢体软组织肉瘤患者,均接受美法仑为基础隔离肢体灌注,联合或不联合重组人肿瘤坏死因子α(分别为TM-ILP和M-ILP)。
  • 反应通过影像学(磁共振成像)和/或临床反应评估,其中M-ILP被排除在反应评估之外。

主要发现

  • 最常见的三种组织学亚型为未分化多形性肉瘤17%(n=184)、滑膜肉瘤16%(n=175)和黏液纤维肉瘤8%(n=87)。
  • 93%的患者使用重组人肿瘤坏死因子α(TM-ILP),与M-ILP相比总体反应率显著更优(p=0.031)、完全缓解率显著更高(p<0.001),各组织学亚组间无显著差异。
  • TM-ILP的总体反应率为68%,包括17%完全缓解;另有80%显示疾病进展。
  • 卡波西肉瘤完全缓解42%、总体反应率96%(均p<0.001);血管肉瘤完全缓解45%(p<0.001);透明细胞肉瘤完全缓解31%(p=0.049)。
  • 80%的患者在隔离肢体灌注后≤6个月内接受切除术;总体保肢率为88%,各组织学亚组间无显著差异,但灌注有反应者保肢率显著高于无反应者(93% vs 76%,p<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to investigate the response rates of different extremity soft-tissue sarcoma subtypes (eSTS) after isolated limb perfusion (ILP), based on an international multi-centre study. MATERIALS AND METHODS: The retrospective cohort comprised eSTS patients from 17 specialised ILP centres that underwent melphalan-based ILP, with or without recombinant human tumour necrosis factor (rhTNFα) (TM-ILP and M-ILP, respectively). Response was measured on imaging (magnetic resonance imaging) and/or clinical response, for which M-ILPs were excluded. RESULTS: A total of 1109 eSTS patients were included. The three most common histological subtypes were undifferentiated pleomorphic sarcoma (17%, n = 184), synovial sarcoma (16%, n = 175) and myxofibrosarcoma (8%, n = 87). rhTNFα was used in 93% (TM-ILP) and resulted in a significantly better overall response rate (ORR, p = 0.031) and complete responses (CR, p < 0.001) in comparison to M-ILP, without significant differences among histological subgroups. The ORR of TM-ILP was 68%, including 17% CR. Also, 80% showed progressive disease. Significantly higher response rates were shown for Kaposi sarcoma (KS) with 42% CR and 96% ORR (both p < 0.001), and significantly higher CR rates for angiosarcoma (AS, 45%, p < 0.001) and clear cell sarcoma (CCS, 31%, p = 0.049). ILP was followed by resection ≤ 6 months in 80% of the patients. The overall limb salvage rate was 88%, without significant differences among histological subgroups, but was significantly higher for ILP responders compared to non-responders (93% versus 76%, p < 0.001). CONCLUSION: ILP resulted in high response and LRS among all eSTS subtypes, however, with significant differences between subtypes with most promising results for KS, AS and CCS.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Reijers SJM, Davies E, Grünhagen DJ, et al. Variation in response rates to isolated limb perfusion in different soft-tissue tumour subtypes: an international multi-centre study. Eur J Cancer. 2023. PMID: 37453241. doi:10.1016/j.ejca.2023.112949

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。